Evolus Inc reports results for the quarter ended in June - Earnings Summary

Evolus

31/07/2024 22:53

* Evolus Inc  EOLS.OQ  reported a quarterly adjusted loss
of 4
cents​​ per share for the quarter ended in June, higher than the
same quarter last year, when the company reported EPS of -19
cents.  The mean expectation of seven analysts for the quarter
was for a loss of 5 cents per share. Wall Street expected
results to range from -11 cents to -3 cents per share.
    * Revenue rose 35.6% to $66.91 million from a year ago;
analysts
expected $65.78 million. 
    * Evolus Inc's reported EPS for the quarter was a loss of 18
cents​.
    * The company reported a quarterly loss of $11.35 million.
    * Evolus Inc shares had risen by 12.4% this quarter and
gained 15.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 17.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Evolus Inc is
$23.00 
This summary was machine generated from LSEG data July 31 at
09:52 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.05          -0.04          Beat
 Mar. 31 2024      -0.10          -0.09          Beat
 Dec. 31 2023      -0.07          -0.12          Missed
 Sep. 30 2023      -0.17          -0.16          Beat